To simultaneously analyze tumor microenvironment-related factors, the panel also included pan-cytokeratin (pCK) as an epithelial marker, CD3 and CD68 as immune markers, and alpha smooth muscle actin (aSMA) as a fibroblastic and vascular endothelial marker (Figure 5A). The gene discussed is CD68; the disease is neoplasm.